| NAME |
DIHYDROCODEINE 16MG/ACETAMINOPHEN 320.5MG/CAFFEINE 30MG CAP |
| VA GENERIC NAME |
ACETAMINOPHEN/CAFFEINE/DIHYDROCODEINE |
| DOSAGE FORM |
CAP,ORAL |
| FDA MED GUIDE |
Dihydrocodeine-Acetaminophen-Caffeine_(Trezix)_(2021).pdf |
| ACTIVE INGREDIENTS |
|
| CS FEDERAL SCHEDULE |
Schedule III |
| SINGLE/MULTI SOURCE PRODUCT |
Multisource |
| NATIONAL FORMULARY NAME |
ACETAMINOPHEN/CAFFEINE/DIHYDROCODEINE CAP,ORAL |
| CREATE DEFAULT POSSIBLE DOSAGE |
YES |
| CODING SYSTEM |
|
| COPAY TIER |
-
- COPAY TIER LEVEL: 2
- COPAY EFFECTIVE DATE: 2017-02-27 00:00:00
|
| PGX ELIGIBLE |
NO |
| PGX SUPPRESSED |
NO |
| VA PRINT NAME |
TREZIX 16MG/320.5MG/30MG CAP |
| VA PRODUCT IDENTIFIER |
T0884 |
| TRANSMIT TO CMOP |
NO |
| VA DISPENSE UNIT |
CAP |
| MASTER ENTRY FOR VUID |
YES |
| VUID |
4033973 |
| EFFECTIVE DATE/TIME |
-
- 2014-12-19 00:00:00
- STATUS: ACTIVE
|